In the fourth quarter of fiscal year 2025, HQY reported earnings per share of 69 cents, missing the Zacks Consensus Estimate ...

HealthEquity stock drops after mixed Q4 results despite 18.8% revenue growth. Click here to find out why HQY stock is a Hold.

HealthEquity, Inc. (NASDAQ:HQY) reported fourth-quarter adjusted EPS of 69 cents, up from 63 cents a year ago, missing the ...

HealthEquity (NASDAQ:HQY) is down nearly 15% in the past month, presenting a potential buying opportunity. The company ...

The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Wasatch Global Investors, an asset management company, released its “Wasatch Long/Short Alpha Fund” fourth-quarter 2024 ...

JMP Securities analyst Constantine Davides maintained a Buy rating on Healthequity (HQY – Research Report) today and set a price target of ...

Citizens JMP analyst Constantine Davides lowered the firm’s price target on HealthEquity (HQY) to $110 from $120 and keeps an Outperform rating ...

HQY stock wiped out its Trump election rally as the health savings account leader's earnings missed on elevated fraud costs.

HealthEquity (HQY) came out with quarterly earnings of $0.69 per share, missing the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.63 per share a year ago.

For the quarter ended January 2025, HealthEquity (HQY) reported revenue of $311.82 million, up 18.8% over the same period last year. EPS came in at $0.69, compared to $0.63 in the year-ago quarter.